New LAMP-based test systems are now just coming to market, which are similar to proposed «Isotherm»:
- Abbott has received emergency use authorization (EUA) from the U.S. FDA for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19) on March 27th 2020 to be used with Abbot ID Now platform;
- Optigene. Details are in the table below.
While being similar in test technology (LAMP PCR), those new test systems are still remaining relatively expensive: Analyzers est. at $9-12k or more. Those devices (from Abbott and similar) keep relatively complicated bio-sample preparation procedures, which limit their use to professional labs. "Isotherm" enables broader field use, bringing test ability to the closest edge of pandemic fight.